IthaID: 3483



Names and Sequences

Functionality: Globin gene causative mutation Pathogenicity: Pathogenic / Likely Pathogenic
Common Name: CD 121 GAA>-AA HGVS Name: HBB:c.364delG
Hb Name: Hb Mahasarakham Protein Info: N/A

Also known as:

Comments: Single nucleotide deletion (-G) generating a frameshift, which results in an elongated β-globin and a modified C-terminal sequence. Found as a compound heterozygote with Hb E variant in a 2-year-old proband with transfusion-dependent beta-thalassaemia.

We follow the HGVS sequence variant nomenclature and IUPAC standards.

External Links

Phenotype

Hemoglobinopathy Group: Thalassaemia and Structural Haemoglobinopathy
Hemoglobinopathy Subgroup: β-thalassaemia, β-chain variant
Allele Phenotype:Dominant
Stability: N/A
Oxygen Affinity: N/A
Associated Phenotypes: N/A

Location

Chromosome: 11
Locus: NG_000007.3
Locus Location: 6394
Size: 1 bp
Located at: β
Specific Location: Exon 3

Other details

Type of Mutation: Point-Mutation(Deletion)
Effect on Gene/Protein Function: Frameshift (Translation)
Ethnic Origin: Thai
Molecular mechanism: N/A
Inheritance: Dominant
DNA Sequence Determined: Yes

In silico pathogenicity prediction

Sequence Viewer

Note: The NCBI Sequence Viewer is not installed on the ITHANET servers but it is embedded in this page from the NCBI. Therefore, IthaGenes has no responsibility over any temporary unavailability of the service. In such a case, please Refresh the page or retry at a later stage. Otherwise, use this external link.

Publications / Origin

  1. Nuinoon M, Thipthara O, Fucharoen S, Compound Heterozygote for a Novel Elongated C-Terminal β-Globin Variant (: c.364delG) and Hb E (: c.79G>A) with Heterozygous α-Thalassemia-2., Hemoglobin, 43(1), 52-55, 2019 PubMed
Created on 2019-11-04 14:45:36, Last reviewed on 2019-11-04 14:55:47 (Show full history)

Disclaimer: The information on this website is provided as an information resource only and must not to be used as a substitute for professional diagnosis and treatment. The ITHANET Portal and IthaGenes are not responsible or liable for any advice, course of treatment, diagnosis or any other information, services or products that an individual obtains through this website.